EOM Pharmaceuticals Holdings, Inc. IMUC
OTC PK
| 09/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | ||
|---|---|---|---|---|---|
| Net Income | -- | -785.30K | -2.95M | -- | |
| Total Depreciation and Amortization | -- | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -41.10K | 2.51M | -- | |
| Change in Net Operating Assets | -- | 273.00K | -415.10K | -- | |
| Cash from Operations | -- | -553.40K | -850.60K | -- | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -- | -- | -- | -- | |
| Total Debt Issued | -- | -- | 1.30M | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 1.02M | -- | |
| Cash from Financing | -- | -- | 2.32M | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | -- | |
| Net Change in Cash | -- | -553.40K | 1.47M | -- | |